Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis.
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905, USA.
L C
LC
Hofbauer
A E
AE
Heufelder
D000818:Animals; D001862:Bone Resorption / Q000378:metabolism; D002352:Carrier Proteins; D016207:Cytokines / Q000502:physiology; D006023:Glycoproteins / Q000378:metabolism* / Q000502:physiology*; D006801:Humans; D008024:Ligands; D008562:Membrane Glycoproteins; D008565:Membrane Proteins / Q000502:physiology; D010010:Osteoclasts / Q000378:metabolism / Q000502:physiology*; D053244:Osteoprotegerin; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology
D002352:Carrier Proteins; D016207:Cytokines; D006023:Glycoproteins; D008024:Ligands; D008562:Membrane Glycoproteins; D008565:Membrane Proteins; D053244:Osteoprotegerin; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C505686:TNFRSF11A protein, human; C506030:TNFRSF11B protein, human; C505688:TNFSF11 protein, human